Epigenomics Ag Stock Analysis
| EPGNF Stock | USD 0.79 0.00 0.00% |
Epigenomics AG is overvalued with Real Value of 0.66 and Hype Value of 0.79. The main objective of Epigenomics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Epigenomics AG is worth, separate from its market price. There are two main types of Epigenomics' stock analysis: fundamental analysis and technical analysis.
The Epigenomics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Epigenomics' ongoing operational relationships across important fundamental and technical indicators.
Epigenomics |
Epigenomics Pink Sheet Analysis Notes
About 35.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.39. Some equities with similar Price to Book (P/B) outperform the market in the long run. Epigenomics AG recorded a loss per share of 0.3. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 27th of December 2022. Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 36 people.The quote for Epigenomics AG is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Epigenomics AG call Gregory Hamilton at 49 30 243 450 or check out https://www.epigenomics.com.Epigenomics AG Investment Alerts
| Epigenomics AG generated a negative expected return over the last 90 days | |
| Epigenomics AG has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 6.2 M. Net Loss for the year was (2.43 M) with profit before overhead, payroll, taxes, and interest of 6.07 M. | |
| Epigenomics AG has accumulated about 15.77 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 35.0% of the company shares are held by company insiders |
Epigenomics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Epigenomics's market, we take the total number of its shares issued and multiply it by Epigenomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Epigenomics AG technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Epigenomics AG Price Movement Analysis
The output start index for this execution was thirty-nine with a total number of output elements of twenty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Epigenomics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Epigenomics AG. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Epigenomics Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Epigenomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Epigenomics shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Epigenomics. By using and applying Epigenomics Pink Sheet analysis, traders can create a robust methodology for identifying Epigenomics entry and exit points for their positions.
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 36 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Epigenomics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Complementary Tools for Epigenomics Pink Sheet analysis
When running Epigenomics' price analysis, check to measure Epigenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epigenomics is operating at the current time. Most of Epigenomics' value examination focuses on studying past and present price action to predict the probability of Epigenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epigenomics' price. Additionally, you may evaluate how the addition of Epigenomics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |